ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CHMP recommends approval of UCB’s Bimzelx for plaque psoriasis
June 29, 2021The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval for UCB’s Bimzelx as a treatment for moderate-to-severe plaque psoriasis. -
Focusing on Interior and Exterior: the Chinese Psoriasis Drug Market to Usher in a Great Change
October 25, 2019Eli Lilly announced on Sep. 4 that its new psoriasis drug: ixekizumab (Taltz®) had entered China and passed the marketing approval of the NMPA, which is another blockbuster psoriasis drug approved following the approval of the “first-in-class” new drug be -
FDA approves the inclusion of new evidence for Cosentyx in PsA
April 25, 2019The FDA has approved the inclusion of new evidence that Cosentyx significantly slows the progression of joint structural damage...
Pharma Sources Insight January 2025
